SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-144470
Filing Date
2024-05-22
Accepted
2024-05-22 07:59:02
Documents
20
Period of Report
2024-05-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d812513d8k.htm   iXBRL 8-K 33069
2 EX-1.1 d812513dex11.htm EX-1.1 223336
3 EX-5.1 d812513dex51.htm EX-5.1 10365
4 EX-99.1 d812513dex991.htm EX-99.1 9504
8 GRAPHIC g812513g0522055857445.jpg GRAPHIC 1649
9 GRAPHIC g812513g0522060047594.jpg GRAPHIC 6662
10 GRAPHIC g812513g0522062611349.jpg GRAPHIC 3002
11 GRAPHIC g812513g0522062611541.jpg GRAPHIC 631
  Complete submission text file 0001193125-24-144470.txt   486586

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dyn-20240521.xsd EX-101.SCH 2848
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyn-20240521_lab.xml EX-101.LAB 17979
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyn-20240521_pre.xml EX-101.PRE 11258
23 EXTRACTED XBRL INSTANCE DOCUMENT d812513d8k_htm.xml XML 3627
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 24971659
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)